D. Nashan

1.3k total citations
41 papers, 762 citations indexed

About

D. Nashan is a scholar working on Dermatology, Oncology and Epidemiology. According to data from OpenAlex, D. Nashan has authored 41 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Dermatology, 11 papers in Oncology and 10 papers in Epidemiology. Recurrent topics in D. Nashan's work include Cutaneous lymphoproliferative disorders research (10 papers), Cutaneous Melanoma Detection and Management (9 papers) and Sperm and Testicular Function (8 papers). D. Nashan is often cited by papers focused on Cutaneous lymphoproliferative disorders research (10 papers), Cutaneous Melanoma Detection and Management (9 papers) and Sperm and Testicular Function (8 papers). D. Nashan collaborates with scholars based in Germany, India and United States. D. Nashan's co-authors include Eberhard Nieschlag, Trevor G. Cooper, Clemens Sorg, Ching‐Hei Yeung, Thomas A. Luger, Rudolf Stadler, Hermann M. Behre, Sonja Ständer, Walter Hubert and F. Jockenhövel and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, The Journal of Urology and British Journal of Cancer.

In The Last Decade

D. Nashan

38 papers receiving 730 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Nashan Germany 17 243 201 189 180 179 41 762
Carl Georg Schirren Germany 19 160 0.7× 353 1.8× 144 0.8× 199 1.1× 65 0.4× 96 965
Dariush Moussai United States 8 22 0.1× 96 0.5× 228 1.2× 168 0.9× 660 3.7× 8 1.1k
A. Whyte United Kingdom 17 64 0.3× 26 0.1× 74 0.4× 352 2.0× 466 2.6× 63 1.1k
Aarne I. Koskimies Finland 19 618 2.5× 21 0.1× 54 0.3× 207 1.1× 287 1.6× 52 1.1k
Chiharu Hiramine Japan 13 117 0.5× 30 0.1× 41 0.2× 116 0.6× 334 1.9× 52 551
Veselina Korcheva United States 11 25 0.1× 61 0.3× 90 0.5× 154 0.9× 214 1.2× 16 631
A. Selma Dagtas United States 8 22 0.1× 26 0.1× 113 0.6× 119 0.7× 506 2.8× 8 803
Rebecca A. Phillips United States 12 151 0.6× 15 0.1× 97 0.5× 185 1.0× 299 1.7× 18 750
Hisato Koshiba Japan 19 909 3.7× 11 0.1× 67 0.4× 83 0.5× 491 2.7× 27 1.2k
Eva Schneider Germany 9 158 0.7× 18 0.1× 33 0.2× 78 0.4× 267 1.5× 15 494

Countries citing papers authored by D. Nashan

Since Specialization
Citations

This map shows the geographic impact of D. Nashan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Nashan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Nashan more than expected).

Fields of papers citing papers by D. Nashan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Nashan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Nashan. The network helps show where D. Nashan may publish in the future.

Co-authorship network of co-authors of D. Nashan

This figure shows the co-authorship network connecting the top 25 collaborators of D. Nashan. A scholar is included among the top collaborators of D. Nashan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Nashan. D. Nashan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kähler, Katharina C., D. Nashan, David Rafei‐Shamsabadi, et al.. (2023). Preferences of German and Swiss melanoma patients for toxicities versus melanoma recurrence during adjuvant treatment (GERMELATOX-A-trial). Journal of Cancer Research and Clinical Oncology. 149(13). 11705–11718. 2 indexed citations
2.
Nashan, D., et al.. (2023). Nützliches Wissen zu Tätowierungen. Die Dermatologie. 74(7). 543–553. 1 indexed citations
3.
Nashan, D., et al.. (2018). Primär kutane Lymphome – eine Fallserie von 163 Patienten. Der Hautarzt. 69(12). 1014–1020. 2 indexed citations
4.
Eigentler, Thomas, Ralf Gutzmer, Axel Hauschild, et al.. (2016). Adjuvant treatment with pegylated interferon α-2a versus low-dose interferon α-2a in patients with high-risk melanoma: a randomized phase III DeCOG trial. Annals of Oncology. 27(8). 1625–1632. 24 indexed citations
5.
Albrecht, K., et al.. (2013). Psychoonkologische Versorgung für Melanompatienten: Konzeption und Implementierung. Der Hautarzt. 64(12). 927–930.
6.
Geissler, Edward K., et al.. (2011). Necrobiosis lipoidica. Der Hautarzt. 62(8). 621–624. 2 indexed citations
7.
Tsianakas, Athanasios, Peter Hensen, D. Nashan, et al.. (2011). Comparison of pegylated interferon α‐2b plus psoralen PUVA versus standard interferon α‐2a plus PUVA in patients with cutaneous T‐cell lymphoma. Journal of the European Academy of Dermatology and Venereology. 26(1). 71–78. 20 indexed citations
8.
Pflugfelder, Annette, Ulrike Leiter, Benjamin Weide, et al.. (2011). Open label randomized study comparing 3 months vs. 6 months treatment of actinic keratoses with 3% diclofenac in 2.5% hyaluronic acid gel: a trial of the German Dermatologic Cooperative Oncology Group. Journal of the European Academy of Dermatology and Venereology. 26(1). 48–53. 40 indexed citations
9.
Nashan, D., et al.. (2009). Diagnostic value of scrotal sonography in infertile men. Andrologia. 22(5). 387–395. 11 indexed citations
10.
Kurschat, Peter, Sabine A. Eming, D. Nashan, Thomas Krieg, & Cornelia Mauch. (2007). Early increase in serum levels of the angiogenesis-inhibitor endostatin and of basic fibroblast growth factor in melanoma patients during disease progression. British Journal of Dermatology. 156(4). 653–658. 23 indexed citations
11.
Volz‐Thomas, A., et al.. (2006). Mastix, a known herbal allergen, as causative agent in occupation‐related dermatitis. Contact Dermatitis. 54(6). 346–347. 1 indexed citations
12.
Nashan, D., Cord Sunderkötter, Gisela Bonsmann, Thomas A. Luger, & Sergij Goerdt. (2006). Chronic urticaria, arthralgia, raised erythrocyte sedimentation rate and IgG paraproteinaemia: a variant of Schnitzler's syndrome?. British Journal of Dermatology. 133(1). 132–134. 16 indexed citations
13.
Luger, TA, et al.. (2004). Imiquimod, pegyliertes Interferon-?-2b und Interleukin-2 in der Behandlung kutaner Melanommetastasen. Der Hautarzt. 55(2). 176–181. 9 indexed citations
14.
Hauschild, Axel, Claus Garbe, W. Stolz, et al.. (2001). Dacarbazine and interferon α with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG). British Journal of Cancer. 84(8). 1036–1042. 64 indexed citations
15.
August, C., Hideo A. Baba, D. Nashan, et al.. (2001). Endometrial metastasiertes "Balloon"-Zell-Melanom unter dem Bild einer "xanthomatösen Endometritis". Der Pathologe. 22(2). 145–150. 6 indexed citations
16.
Frieling, Uta, D. Nashan, & Dieter Metze. (1999). Kutane Myiasis - ein Urlaubssouvenir. Der Hautarzt. 50(3). 203–207. 11 indexed citations
17.
Yeung, Ching‐Hei, D. Nashan, Clemens Sorg, et al.. (1994). Basal Cells of the Human Epididymis—Antigenic and Ultrastructural Similarities to Tissue-Fixed Macrophages1. Biology of Reproduction. 50(4). 917–926. 81 indexed citations
18.
Nashan, D., Christian A. Jantos, Michael Bergmann, et al.. (1993). Immuno‐competent cells in the murine epididymis following infection with Escherichiu coli. International Journal of Andrology. 16(1). 47–52. 18 indexed citations
19.
Cooper, Trevor G., Ching‐Hei Yeung, D. Nashan, F. Jockenhövel, & Eberhard Nieschlag. (1990). Improvement in the assessment of human epididymal function by the use of inhibitors in the assay of α‐glucosidase in seminal plasma. International Journal of Andrology. 13(4). 297–305. 60 indexed citations
20.
Nashan, D., Ulrich A. Knuth, Gottfried Weidinger, & Eberhard Nieschlag. (1989). The antimycotic drug terbinafine in contrast to ketoconazole lacks acute effects on the pituitary-testicular function of healthy men: a placebo-controlled double-blind trial. European Journal of Endocrinology. 120(5). 677–681. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carl Georg Schirren Breakdown of academic impact, for papers by Dariush Moussai Breakdown of academic impact, for papers by A. Whyte Breakdown of academic impact, for papers by Aarne I. Koskimies Breakdown of academic impact, for papers by Chiharu Hiramine Breakdown of academic impact, for papers by Veselina Korcheva Breakdown of academic impact, for papers by A. Selma Dagtas Breakdown of academic impact, for papers by Rebecca A. Phillips Breakdown of academic impact, for papers by Hisato Koshiba Breakdown of academic impact, for papers by Eva Schneider
Rankless by CCL
2026